Literature DB >> 19333779

Very long-chain acyl-CoA dehydrogenase deficiency: the effects of accidental fat loading in a patient detected through newborn screening.

C Ficicioglu1, C Hussa.   

Abstract

Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is an autosomal recessive disorder of fatty acid oxidation. The majority of patients with VLCADD can be detected through newborn screening (NBS) with elevated levels of the tetradecanoyl carnitine species. An 11-month-old infant, diagnosed with late-onset VLCADD (genotype: T848C/G1322A) through newborn screening at birth, was admitted with emesis, severe lethargy, limpness in extremities, loss of muscle tone and an elevated CK level. He was mistakenly given Ketocal formula (about 8 g/kg per day long-chain fat-over six times his usual intake) instead of his usual Monogen formula for 2.5 days before being admitted. Once admitted, he was started on Monogen and IV (10% dextrose) fluids. He was discharged home after four days in the hospital without any sequelae of this accidental fat loading event. The report highlights several important points about this particular case and more generally about patients with VLCADD detected through NBS: (1) the amount of time in which patients might become severely symptomatic and the nature of these symptoms after fat loading; (2) the time frame for complete recovery after beginning of treatment; (3) the importance of alerting home-care companies and families about formula delivery errors and their repercussions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333779     DOI: 10.1007/s10545-009-1143-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

1.  Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.

Authors:  Ina Schymik; Michaela Liebig; Martina Mueller; Udo Wendel; Ertan Mayatepek; Arnold W Strauss; Ronald J A Wanders; Ute Spiekerkoetter
Journal:  J Pediatr       Date:  2006-07       Impact factor: 4.406

2.  Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.

Authors:  J C Wood; M J Magera; P Rinaldo; M R Seashore; A W Strauss; A Friedman
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

3.  Management of fatty acid oxidation disorders: a survey of current treatment strategies.

Authors:  Java O Solis; Rani H Singh
Journal:  J Am Diet Assoc       Date:  2002-12

4.  MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Ute Spiekerkoetter; Bin Sun; Thomas Zytkovicz; Ronald Wanders; Arnold W Strauss; Udo Wendel
Journal:  J Pediatr       Date:  2003-09       Impact factor: 4.406

5.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

6.  Effects of a fat load and exercise on asymptomatic VLCAD deficiency.

Authors:  U Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

7.  VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis.

Authors:  A Boneh; B S Andresen; N Gregersen; M Ibrahim; N Tzanakos; H Peters; J Yaplito-Lee; J J Pitt
Journal:  Mol Genet Metab       Date:  2006-02-20       Impact factor: 4.797

8.  A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency.

Authors:  Georgianne L Arnold; Johan Van Hove; Debra Freedenberg; Arnold Strauss; Nicola Longo; Barbara Burton; Cheryl Garganta; Can Ficicioglu; Stephen Cederbaum; Cary Harding; Richard G Boles; Dietrich Matern; Pranesh Chakraborty; Annette Feigenbaum
Journal:  Mol Genet Metab       Date:  2009-01-20       Impact factor: 4.797

  8 in total
  1 in total

Review 1.  Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Kenji Yamada; Takeshi Taketani
Journal:  J Hum Genet       Date:  2018-11-06       Impact factor: 3.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.